Virginia Tech Oct 8 2025 Scientists at the Fralin Biomedical Research Institute at VTC and their collaborators are exploring emerging trends in cancer immunotherapy, with back-to-back review articles published in  Nature Cancer  and  Trends in Cancer  that look at how nanotechnology could reprogram the immune system and help overcome tumors' defenses. Both papers highlight how nanoengineering strategies are emerging as powerful tools to address limitations of current immunotherapies,